The largest study to examine outcomes for patients treated outside a clinical trial setting with a minimally invasive procedure to repair a poorly functioning mitral valve in the heart found that the ...

PHOENIX -- Global experience with the novel Intrepid transapical transcatheter mitral valve replacement (TMVR) device through 2 years showed high risks of mortality and complications, raising concerns ...

The largest study to examine outcomes for patients treated outside a clinical trial setting with a minimally invasive procedure to repair a poorly functioning mitral valve in the heart found that the ...

Polares Medical has secured $50m through a Series C financing round to further support the development of its novel cardiac ...

Please provide your email address to receive an email when new articles are posted on . Employing intravascular lithotripsy facilitated transcatheter mitral valve replacement in a patient with severe ...

Please provide your email address to receive an email when new articles are posted on . A transcatheter mitral valve replacement system was approved for patients at high surgical risk. The system is ...

Overview The global Transcatheter Mitral Valve Replacement (TMVR) market is witnessing rapid expansion and is expected to grow at a strong CAGR of nearly 20% during the forecast period. The increasing ...

These findings were published in early 2026 in Cardiovascular Revascularization Medicine. The Clinical Challenge of Mitral Regurgitation. Mitral Regurgitation (MR) remains a preva ...

In patients who had undergone transcatheter edge-to-edge (TEER) mitral valve repair and required reintervention, less than 5% underwent a surgical mitral valve repair rather than a replacement ...

For patients with failing bioprosthetic surgical mitral valves, the transcatheter mitral valve-in-valve (ViV) procedure provides early outcomes similar to those seen with repeat surgical replacement, ...

Their findings on the condition called degenerative mitral regurgitation were published today in the peer-reviewed Journal of the American Medical Association (JAMA), representing the largest study to ...

After years of interest in and anticipation about the potential for transcatheter mitral valve replacement (TMVR), Edwards Lifesciences is ready to kick off a CE Mark trial for its TMVR system. The ...